2023
December 7th
December 9th
Poster Course on Urothelial Cancers 2023
International course

1st Course on Urothelial Cancers 2023: tumor heterogeneity and therapeutic resistance

The aim of this course is to provide a practical and up-to-date overview of the latest research and clinical developments in urothelial cancer, including muscle-invasive and non-muscle invasive bladder cancers, upper urinary tract urothelial carcinomas, and their metastases. In so doing, we aim to a) promote a consensus understanding of the current optimal treatment strategies for these diseases, b) provide practical knowledge and a clinical perspective of the diseases and how they are treated, c) promote an enhanced mechanistic understanding of the diseases and the methodologies used to study them, and d) provide an industry perspective to share how new treatments are developed.

Course in English
Registration deadline

Presentation

Objectives

Upon successful completion of this course, students will be able to:

1) Discuss new discoveries and preclinical models in urothelial cancer research regarding tumor heterogeneity and therapeutic resistance

2) Explain cutting-edge preclinical research techniques, including single-cell and spatial omics approaches, and asses their clinical potential for urothelial cancers

3) Describe the stages of drug and technology development

4) Compare and contrast current and developing treatments in urothelial cancer care

5) As a team, formulate a plan for cancer care, given a particular urothelial cancer case

6) Discuss and debate ethical issues related to urothelial cancer treatments and research

Discussion & Workshops

N/A

Personal Work

N/A

ECTS Information

N/A

Exam & Evaluation

N/A

Practical Informations

Practical Informations

Basic knowledge in Urology, open to medical doctors and scientists

Selection result
Late October
There is no registration fee for this course
Place
Institut Curie - Bâtiment de Biologie du Développement - Amphithéâtre
11 Rue Pierre et Marie Curie
75248 Paris cedex 05
France

Maximum Number of Participants

60 people

Number of Participants

60 participants

Selection Criteria

 Selection on CV and motivation letter (short paragraph, not more than 200 words)

Speakers

Speakers

Keynote speaker : Lars DYRSKJØT - DK

 

Ferran ALGABA - ES

Yves ALLORY - FR

Claire Béraud - FR

Isabelle BERNARD-PIERROT - FR

Julia BONASTRE - FR

Lori CIREFICE - FR

Lars DYRSKJØT - DK

Aude FLECHON - FR

Christophe GINESTIER - FR

Nadine HOUEDE - FR

Molly INGERSOLL - FR

William KIM - US

Florence LE CALVEZ-KELM - FR

Seth LERNER - US

Yohann LORIOT - FR

Núria MALATS - ES

Yann NEUZILLET - FR

Remy NICOLLE - FR

François RADVANYI - FR

Morgan ROUPRÊT - FR

Mark RUBIN - CH

Florian SCOTTÉ - FR

Roland SEILER - CH

Gottfrid SJÖDAHL - SE

Eric TARTOUR - FR

 

Keynote speakers

Lars DYRSKJØT - DK

This list of speakers may still change

Organizers

François Radvanyi, UMR144, Équipe Oncologie Moléculaire

Isabelle Bernard-Pierrot, UMR144, Oncologie Moléculaire

Yves Allory, UMR144, Oncologie Moléculaire

Phillipe Beuzeboc, Hopital Foch

Yann Neuzillet, Hopital Foch

Therese Wilhelm, UMR144, Oncologie Moléculaire

Supported by

Organization

  • Advanced Training Office - Institut Curie